We found that PCDs effectively improved the symptoms associated with RLS. While a placebo effect was observed, therapeutic PCDs resulted in significantly greater improvements in disease severity, ...
NEW YORK (Reuters Health) - The results of a study suggest that compression devices can produce significant improvements in patients with restless legs syndrome, a movement disorder that causes ...
PLEASANTON, Calif., Jan. 16, 2024 /PRNewswire/ -- Noctrix Health, Inc. announced today that it has closed a $40M Series C financing round led by Sectoral Asset Management with participation from other ...
The FDA has cleared Sensory Medical Inc. to sell Relaxis, a device that the San Clemente, CA-based company is touting as the first noninvasive, nonpharmacological treatment to help improve the quality ...
Restless legs syndrome (RLS), also known as Willis-Ekbom Disease, is a neurological condition that affects about 7% of people. Typical symptoms include an irresistible urge to move your legs, ...
DARIEN, IL - A new clinical practice guideline developed by the American Academy of Sleep Medicine provides updated recommendations for the treatment of restless legs syndrome. The guideline reflects ...
Restless legs syndrome: a new practice guideline Evidence shows strong support for prescribing pramipexole, rotigotine, cabergoline, or gabapentin enacarbil to treat adults with restless legs syndrome ...
*Values are given as the mean ± SD, unless otherwise indicated.
Lancaster University provides funding as a founding partner of The Conversation UK. Restless legs syndrome (RLS), also known as Willis-Ekbom Disease, is a neurological condition that affects about 7% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback